Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
TRMK Stock Summary
Top 10 Correlated ETFs
TRMK
In the News
Outlook on 5 Regional Banks Lowered by S&P on CRE Exposure
S&P Ratings downgrades the outlook on First Commonwealth, M&T Bank (MTB), Synovus (SNV), Trustmark (TRMK) and Valley National (VLY) to negative from stable.
Should Value Investors Buy Trustmark (TRMK) Stock?
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Best Income Stocks to Buy for March 7th
TROW, MBWM and TRMK made it to the Zacks Rank #1 (Strong Buy) income stocks list on March 7, 2023.
Are Investors Undervaluing Trustmark (TRMK) Right Now?
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Trustmark (TRMK) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates
Although the revenue and EPS for Trustmark (TRMK) give a sense of how its business performed in the quarter ended December 2023, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Trustmark (TRMK) Q4 Earnings and Revenues Top Estimates
Trustmark (TRMK) came out with quarterly earnings of $0.61 per share, beating the Zacks Consensus Estimate of $0.57 per share. This compares to earnings of $0.68 per share a year ago.
Trustmark Corporation to Announce Fourth Quarter Financial Results January 23 and Conduct Earnings Conference Call January 24
JACKSON, Miss.--(BUSINESS WIRE)--Trustmark Corporation to Announce Fourth Quarter Financial Results January 23 and Conduct Earnings Conference Call January 24.
Trustmark Corporation (TRMK) Q3 2023 Earnings Call Transcript
Trustmark Corporation (NASDAQ:TRMK ) Q3 2023 Earnings Conference Call October 25, 2023 9:30 AM ET Company Participants Joey Rein - Director of Corporate Strategy Duane Dewey - President and Chief Executive Officer Barry Harvey - Chief Credit and Operations Officer Tom Owens - Chief Financial Officer Tom Chambers - Chief Accounting Officer Conference Call Participants Graham Dick - Piper Sandler Kevin Fitzsimmons - D.A. Davidson Will Jones - KBW Operator Good morning, ladies and gentlemen, and welcome to Trustmark Corporation's Third Quarter Earnings Conference Call.
Trustmark (TRMK) Reports Q3 Earnings: What Key Metrics Have to Say
The headline numbers for Trustmark (TRMK) give insight into how the company performed in the quarter ended September 2023, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Trustmark (TRMK) Lags Q3 Earnings Estimates
Trustmark (TRMK) came out with quarterly earnings of $0.64 per share, missing the Zacks Consensus Estimate of $0.69 per share. This compares to earnings of $0.69 per share a year ago.
TRMK Financial details
TRMK Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2023-12-31
Metric | History | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 8.5 | 9.8 | 8.85 | 0.76 | 17.86 | |
Net income per share | 2.33 | 2.52 | 2.35 | 1.17 | 2.71 | |
Operating cash flow per share | 1.8 | 1.03 | 5.55 | 4.84 | 3.68 | |
Free cash flow per share | 1.33 | 0.54 | 5.06 | 4.29 | 2.88 | |
Cash per share | 30.35 | 62.11 | 87.69 | 45.05 | 44.85 | |
Book value per share | 25.7 | 27.42 | 27.73 | 24.37 | 27.22 | |
Tangible book value per share | 198.85 | 247.34 | 267.67 | 15.92 | 18.72 | |
Share holders equity per share | 25.7 | 27.42 | 27.73 | 24.37 | 27.22 | |
Interest debt per share | 4.58 | 7.23 | 5.94 | 22.22 | 18.59 | |
Market cap | 2.23B | 1.73B | 2.04B | 2.14B | 1.7B | |
Enterprise value | 2.05B | 167.14M | 83.66M | 2.68B | 1.84B | |
P/E ratio | 14.82 | 10.84 | 13.83 | 29.74 | 10.29 | |
Price to sales ratio | 4.06 | 2.79 | 3.67 | 45.97 | 1.56 | |
POCF ratio | 19.15 | 26.54 | 5.84 | 7.21 | 7.57 | |
PFCF ratio | 26.02 | 50.25 | 6.42 | 8.14 | 9.66 | |
P/B Ratio | 1.34 | 1 | 1.17 | 1.43 | 1.02 | |
PTB ratio | 1.34 | 1 | 1.17 | 1.43 | 1.02 | |
EV to sales | 3.73 | 0.27 | 0.15 | 57.58 | 1.69 | |
Enterprise value over EBITDA | 11.53 | 0.87 | 0.47 | 31.26 | 8.74 | |
EV to operating cash flow | 17.61 | 2.56 | 0.24 | 9.03 | 8.19 | |
EV to free cash flow | 23.93 | 4.84 | 0.26 | 10.2 | 10.46 | |
Earnings yield | 0.07 | 0.09 | 0.07 | 0.03 | 0.1 | |
Free cash flow yield | 0.04 | 0.02 | 0.16 | 0.12 | 0.1 | |
Debt to equity | 0.13 | 0.24 | 0.2 | 0.88 | 0.65 | |
Debt to assets | 0.02 | 0.03 | 0.02 | 0.07 | 0.06 | |
Net debt to EBITDA | -1.01 | -8.13 | -11 | 6.31 | 0.67 | |
Current ratio | 60.62 | 122.15 | 150.97 | 15.92 | 0.12 | |
Interest coverage | 2.07 | 4.54 | 7.26 | 1.79 | 3.54 | |
Income quality | 0.77 | 0.41 | 2.37 | 4.12 | 1.36 | |
Dividend Yield | 0.03 | 0.03 | 0.03 | 0.03 | 0.03 | |
Payout ratio | 0.4 | 0.37 | 0.39 | 0.79 | 0.34 | |
Sales general and administrative to revenue | 0.46 | 0.45 | 0.53 | 6.34 | 0.29 | |
Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
Intangibles to total assets | 0.03 | 0.03 | 0.03 | 0.03 | 0.03 | |
Capex to operating cash flow | -0.26 | -0.47 | -0.09 | -0.11 | -0.22 | |
Capex to revenue | -0.06 | -0.05 | -0.06 | -0.73 | -0.04 | |
Capex to depreciation | -0.78 | -0.75 | -0.68 | -0.85 | -2.69 | |
Stock based compensation to revenue | 0.01 | 0.01 | 0.01 | 0.1 | 0.01 | |
Graham number | 36.69 | 39.43 | 38.27 | 25.37 | 40.74 | |
ROIC | 0.08 | 0.07 | 0.07 | 0.03 | 0.06 | |
Return on tangible assets | 0.01 | 0.01 | 0.01 | 0 | 0.01 | |
Graham Net | 27.57 | 56.04 | 82.71 | -224.75 | -235.79 | |
Working capital | 1.93B | 3.91B | 5.47B | 580.91M | -7.5B | |
Tangible asset value | 12.85B | 15.71B | 16.81B | 974.71M | 1.14B | |
Net current asset value | 1.78B | 3.56B | 5.19B | -15.9B | -16.07B | |
Invested capital | 0.13 | 0.24 | 0.2 | 0.88 | 0.65 | |
Average receivables | 0 | 0 | 0 | 0 | 0 | |
Average payables | 0 | 0 | 0 | 0 | 0 | |
Average inventory | 0 | 0 | 0 | 0 | 0 | |
Days sales outstanding | 0 | 0 | 0 | 0 | 0 | |
Days payables outstanding | 0 | 0 | 0 | 0 | 0 | |
Days of inventory on hand | 0 | 0 | 0 | 0 | 0 | |
Receivables turnover | 0 | 0 | 0 | 0 | 0 | |
Payables turnover | 0 | 0 | 0 | 0 | 0 | |
Inventory turnover | 0 | 0 | 0 | 0 | 0 | |
ROE | 0.09 | 0.09 | 0.08 | 0.05 | 0.1 | |
Capex per share | -0.48 | -0.49 | -0.5 | -0.56 | -0.8 |
Quarterly Fundamentals Overview
Last date of statement is 2023-12-31 for Q4
Metric | History | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 2.73 | 2.73 | 2.74 | 2.7 | 4.56 | |
Net income per share | -0.56 | 0.82 | 0.74 | 0.56 | 0.59 | |
Operating cash flow per share | 1.12 | 0.04 | 0.39 | 1.74 | 1.01 | |
Free cash flow per share | 0.99 | -0.28 | 0.21 | 1.58 | 0.88 | |
Cash per share | 45.25 | 53.78 | 44.28 | 41.21 | 44.84 | |
Book value per share | 24.48 | 25.6 | 25.73 | 25.71 | 27.21 | |
Tangible book value per share | 15.99 | 17.17 | 272.15 | 275.75 | 18.71 | |
Share holders equity per share | 24.48 | 25.6 | 25.73 | 25.71 | 27.21 | |
Interest debt per share | 22.04 | 29.63 | 22.96 | 18.89 | 19.19 | |
Market cap | 2.13B | 1.51B | 1.29B | 1.33B | 1.7B | |
Enterprise value | 2.67B | 1.92B | 1.74B | 1.6B | 1.84B | |
P/E ratio | -15.62 | 7.49 | 7.16 | 9.75 | 11.78 | |
Price to sales ratio | 12.79 | 9.05 | 7.7 | 8.04 | 6.12 | |
POCF ratio | 31.28 | 588.89 | 54.24 | 12.48 | 27.49 | |
PFCF ratio | 35.37 | -87.35 | 98.91 | 13.79 | 31.58 | |
P/B Ratio | 1.43 | 0.96 | 0.82 | 0.85 | 1.02 | |
PTB ratio | 1.43 | 0.96 | 0.82 | 0.85 | 1.02 | |
EV to sales | 16.03 | 11.52 | 10.39 | 9.68 | 6.62 | |
Enterprise value over EBITDA | -272.23 | 15.82 | 30.99 | 35.67 | 39.44 | |
EV to operating cash flow | 39.22 | 749.58 | 73.2 | 15.02 | 29.75 | |
EV to free cash flow | 44.34 | -111.19 | 133.48 | 16.6 | 34.18 | |
Earnings yield | -0.02 | 0.03 | 0.03 | 0.03 | 0.02 | |
Free cash flow yield | 0.03 | -0.01 | 0.01 | 0.07 | 0.03 | |
Debt to equity | 0.88 | 1.12 | 0.84 | 0.68 | 0.65 | |
Debt to assets | 0.07 | 0.09 | 0.07 | 0.06 | 0.06 | |
Net debt to EBITDA | -55.11 | 3.39 | 8.03 | 6.04 | 3 | |
Current ratio | 15.92 | -3.16 | 66.2 | 58.9 | 0.12 | |
Interest coverage | -0.34 | 1.97 | 0.71 | 0.5 | 0.49 | |
Income quality | -2 | 0.05 | 0.53 | 3.13 | 1.71 | |
Dividend Yield | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | |
Payout ratio | -0.41 | 0.28 | 0.31 | 0.42 | 0.39 | |
Sales general and administrative to revenue | 0.45 | 0.46 | 0.47 | 0.49 | 0.3 | |
Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
Intangibles to total assets | 0.03 | 0.03 | 0.03 | 0.03 | 0.03 | |
Capex to operating cash flow | -0.12 | -7.74 | -0.45 | -0.09 | -0.13 | |
Capex to revenue | -0.05 | -0.12 | -0.06 | -0.06 | -0.03 | |
Capex to depreciation | -0.83 | -2.58 | -1.22 | -1.04 | -0.83 | |
Stock based compensation to revenue | 0.01 | 0.01 | 0.01 | 0.01 | 0 | |
Graham number | 17.54 | 21.79 | 20.66 | 17.96 | 19.03 | |
ROIC | 0 | 0.03 | 0.02 | 0.01 | 0.01 | |
Return on tangible assets | 0 | 0 | 0 | 0 | 0 | |
Graham Net | -225.76 | -230.02 | 23.27 | 24.49 | -235.72 | |
Working capital | 580.91M | -157.89M | 2.66B | 2.47B | -7.5B | |
Tangible asset value | 974.71M | 1.05B | 16.62B | 16.84B | 1.14B | |
Net current asset value | -15.9B | -17.43B | 1.42B | 1.5B | -16.07B | |
Invested capital | 0.88 | 1.12 | 0.84 | 0.68 | 0.65 | |
Average receivables | 0 | 0 | 0 | 0 | 0 | |
Average payables | 0 | 0 | 0 | 0 | 0 | |
Average inventory | 0 | 0 | 0 | 0 | 0 | |
Days sales outstanding | 0 | 0 | 0 | 0 | 0 | |
Days payables outstanding | 0 | 0 | 0 | 0 | 0 | |
Days of inventory on hand | 0 | 0 | 0 | 0 | 0 | |
Receivables turnover | 0 | 0 | 0 | 0 | 0 | |
Payables turnover | 0 | 0 | 0 | 0 | 0 | |
Inventory turnover | 0 | 0 | 0 | 0 | 0 | |
ROE | -0.02 | 0.03 | 0.03 | 0.02 | 0.02 | |
Capex per share | -0.13 | -0.32 | -0.18 | -0.17 | -0.13 |
TRMK Frequently Asked Questions
What is Trustmark Corporation stock symbol ?
Trustmark Corporation is a US stock , located in Jackson of Ms and trading under the symbol TRMK
Is Trustmark Corporation buy or a sell ?
1 stock analysts have 1 predictions with a medium analyst target price of $38. The lowest prediction is $38 and the highest is $38
What is TRMK stock prediction ?
What is Trustmark Corporation stock quote today ?
Trustmark Corporation stock price is $28.06 today.
Is Trustmark Corporation stock public?
Yes, Trustmark Corporation is a publicly traded company.